See every side of every news story

Published 4 hours ago • loading... • Updated 4 hours ago

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

Summary by Bluefield Daily Telegraph

ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split…

2 Articles

2 Articles

Bluefield Daily Telegraph

Aspire Biopharma Holdings, Inc. Announces Approval Of Reverse Stock Split Ratio

ESTERO, FL / ACCESS Newswire / May 7, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that it will effect a one-for-thirty (1:30) reverse stock split…

4 hours ago

Read Full Article

Nasdaq compliance push: Aspire Biopharma enacts 1-for-30 split

Post-split trading begins May 11 under ASBP as the company moves to meet Nasdaq's minimum bid price rule; options and warrants adjust too.

4 hours ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources2

Leaning Left1Leaning Right0Center0Last Updated2 hours agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Untracked bias

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news 4 hours ago on Thursday, May 7, 2026.

Sources are mostly out of (0)

Similar News Topics

Stories disproportionately reported by the Left or the Right

Similar News Topics